Patent directory · USPTO A61K / A61P
Patents matching “Shuttle Pharmaceuticals, Inc.”
9 pharma patents match "Shuttle Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 9 pharmaceutical patents matching "Shuttle Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12357650
Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation
granted -
US 12077515
Selective histone deacetylase inhibitors for the treatment of human disease
granted -
US 11654157
Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation
granted -
US 11584733
Selective histone deacetylase inhibitors for the treatment of human disease
granted -
US 11407723
Selective histone deacetylase inhibitors for the treatment of human disease
granted -
US 11034667
Selective histone deacetylase inhibitors for the treatment of human disease
granted -
US 10745352
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
granted -
US 10730834
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
granted -
US 9809539
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
granted